Literature DB >> 18512131

Association of polymorphisms at restriction enzyme recognition sites of apolipoprotein B and E gene with dyslipidemia in children undergoing primary nephrotic syndrome.

Peng Hu1, Yuan Han Qin, Cheng Xue Jing, Feng Ying Lei, Ping Chen, Ming Fang Li.   

Abstract

BACKGROUND: Dyslipidemia, a common complication, is very prevalent in children with primary nephrotic syndrome (PNS). Recent studies have shown that genetic basis may be involved in the onset of HLP secondary to PNS. ApoB and E have been identified as the important candidate genes for lipid abnormalities.
OBJECTIVE: To investigate the association of apolipoprotein B (apoB) and E (apoE) genetic polymorphisms (Xba I, EcoR I, Msp I, and Hha I) with parameters describing the serum lipid profiles in children undergoing PNS.
METHODS: Genomic DNA was extracted from 250 children diagnosed with PNS and 200 healthy controls with neither allergic nor renal disease. ApoB (Xba I, EcoR I, and Msp I) and apoE (Hha I) genotypes were determined by PCR-restriction fragment length polymorphism (RFLP) analysis. The fasting serum lipoprotein (a) [Lp(a)], total cholesterol (TC), triglyceride (TG), high density lipoprotein cholesterol (HDL-C), low density lipoprotein cholesterol (LDL-C), apolipoprotein A1 (apoA1), apoB, and total protein from a 24-h urine sample were measured.
RESULTS: No significant differences in genotypes and alleles frequencies were observed for the apoB Xba I, EcoR I, Msp I and the apoE Hha I restriction sites in PNS patients as compared to controls (P > 0.05). Patients and controls with X + allele exhibited significantly higher serum levels of Lp(a), TC, nonHDL-C, LDL-C, LDL-C/HDL-C ratio, and apoB than that with X- allele (P < 0.05), whereas for apoA1/B ratio the opposite was found (P < 0.01). E-/E- carriers had significantly higher Lp(a), TC, HDL-C, and apoA1 concentrations than did E+/E- or E+/E+ carriers in control group (P < 0.05). Healthy children carrying the rare EcoR I allele had higher mean Lp(a), TC, and HDL-C levels than homozygotes for E+ (P < 0.05). Higher Lp(a) serum concentrations were observed in patients with E- allele (P < 0.05). No significant differences in lipid parameters were determined for the apoB Msp I and apoE Hha I the polymorphisms study (P > 0.05). When genetic variations were compared with urinary protein excretion, the Xba I X- allele was more frequent in patients with elevated proteinuria (P < 0.01).
CONCLUSION: Presence of Xba I X+ allele and/or EcoR I E- at the apoB gene may be risk factors for lipid abnormalities secondary to childhood PNS.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18512131     DOI: 10.1007/s11033-008-9275-7

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  28 in total

1.  Molecular basis of five apolipoprotein B gene polymorphisms in noncoding regions.

Authors:  L S Huang; M E Ripps; J L Breslow
Journal:  J Lipid Res       Date:  1990-01       Impact factor: 5.922

2.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

3.  Apolipoprotein E polymorphism in childhood nephrotic syndrome.

Authors:  Gulen Attila; Aytul Noyan; Aysun Karabay Bayazit; Esmeray Acartürk; Ali Anarat
Journal:  Pediatr Nephrol       Date:  2002-05       Impact factor: 3.714

4.  Comparison of the LDL-receptor binding of VLDL and LDL from apoE4 and apoE3 homozygotes.

Authors:  C D Mamotte; M Sturm; J I Foo; F M van Bockxmeer; R R Taylor
Journal:  Am J Physiol       Date:  1999-03

5.  DNA polymorphisms of the apolipoprotein B gene (XbaI, EcoRI, and MspI RFLPs) in Norwegians at risk of atherosclerosis and healthy controls.

Authors:  M Delghandi; R Thangarajah; M Nilsen; S Grimsgaard; K H Bønaa; S Tonstad; L Jørgensen
Journal:  Acta Cardiol       Date:  1999-08       Impact factor: 1.718

6.  Apolipoprotein E polymorphism and clinical course in childhood nephrotic syndrome.

Authors:  Sung-Do Kim; Il-Soo Kim; Byung-Cheol Lee; Kang-Duk Choi; Joo-Ho Chung; Chun-Gyoo Ihm; Byoung-Soo Cho
Journal:  Pediatr Nephrol       Date:  2003-02-13       Impact factor: 3.714

7.  Intestinal cholesterol absorption efficiency in man is related to apoprotein E phenotype.

Authors:  Y A Kesäniemi; C Ehnholm; T A Miettinen
Journal:  J Clin Invest       Date:  1987-08       Impact factor: 14.808

Review 8.  Hyperlipidemia in childhood nephrotic syndrome.

Authors:  M A Thabet; J R Salcedo; J C Chan
Journal:  Pediatr Nephrol       Date:  1993-10       Impact factor: 3.714

9.  Restriction fragment length polymorphisms of apolipoprotein B gene in Chinese population with coronary heart disease.

Authors:  J P Pan; A N Chiang; J J Tai; S P Wang; M S Chang
Journal:  Clin Chem       Date:  1995-03       Impact factor: 8.327

10.  The effect of apolipoprotein E polymorphism on lipid levels in Korean adults.

Authors:  Min-Ho Shin; Hee-Nam Kim; Lian-Hua Cui; Sun-Seog Kweon; Kyeong-Soo Park; Heon Heo; Hae-Sung Nam; Seul-Ki Jeong; Eun-Kyung Chung; Jin-Su Choi
Journal:  J Korean Med Sci       Date:  2005-06       Impact factor: 2.153

View more
  12 in total

1.  Microarray analysis of cultured rat hippocampal neurons treated with brain derived neurotrophic factor.

Authors:  Chiara Cazzin; Silvia Mion; Fabrizio Caldara; Joseph M Rimland; Enrico Domenici
Journal:  Mol Biol Rep       Date:  2010-06-10       Impact factor: 2.316

2.  Does the geographical gradient of ApoE4 allele exist in China? A systemic comparison among multiple Chinese populations.

Authors:  Peng Hu; Yuan Han Qin; Cheng Xue Jing; Ling Lu; Bo Hu; Peng Fei Du
Journal:  Mol Biol Rep       Date:  2010-03-31       Impact factor: 2.316

3.  Identification of a recurrent insertion mutation in the LDLR gene in a Pakistani family with autosomal dominant hypercholesterolemia.

Authors:  Muhammad Ajmal; Waqas Ahmed; Ahmed Sadeque; Syeda Hafiza Benish Ali; Syed Habib Bokhari; Nuzhat Ahmed; Raheel Qamar
Journal:  Mol Biol Rep       Date:  2010-03-10       Impact factor: 2.316

4.  Polymorphisms of the MDR1 and MIF genes in children with nephrotic syndrome.

Authors:  Hyun Jin Choi; Hee Yeon Cho; Han Ro; So Hee Lee; Kyung Hee Han; Hyunkyung Lee; Hee Gyung Kang; Il Soo Ha; Yong Choi; Hae Il Cheong
Journal:  Pediatr Nephrol       Date:  2011-05-08       Impact factor: 3.714

5.  Antioxidant activities of recombinant amphioxus (Branchiostoma belcheri) apolipoprotein D.

Authors:  Yu Zhang; Yi Cong; Shaohui Wang; Shicui Zhang
Journal:  Mol Biol Rep       Date:  2010-09-17       Impact factor: 2.316

6.  Association of apoE gene expression and its gene polymorphism with nephrotic syndrome susceptibility: a meta-analysis of experimental and human studies.

Authors:  Tian-Biao Zhou; Yuan-Han Qin; Hui-Ling Xu
Journal:  Mol Biol Rep       Date:  2012-07-04       Impact factor: 2.316

7.  Genetic variants involved in gallstone formation and capsaicin metabolism, and the risk of gallbladder cancer in Chilean women.

Authors:  Sergio Báez; Yasuo Tsuchiya; Alfonso Calvo; Martha Pruyas; Kazutoshi Nakamura; Chikako Kiyohara; Mari Oyama; Masaharu Yamamoto
Journal:  World J Gastroenterol       Date:  2010-01-21       Impact factor: 5.742

Review 8.  Modulation of vitamin D signaling is a potential therapeutic target to lower cardiovascular risk in chronic kidney disease.

Authors:  Peng Hu; Bo Hu; Jing Wang; Ling Lu; Yuan Han Qin
Journal:  Med Sci Monit       Date:  2011-06

9.  Roles of ApoB-100 gene polymorphisms and the risks of gallstones and gallbladder cancer: a meta-analysis.

Authors:  Yi Gong; Leida Zhang; Ping Bie; Huaizhi Wang
Journal:  PLoS One       Date:  2013-04-18       Impact factor: 3.240

10.  Variable frequencies of apolipoprotein E genotypes and its effect on serum lipids in the Guangxi Zhuang and Han children.

Authors:  Peng Hu; Yuan Han Qin; Feng Ying Lei; Juan Pei; Bo Hu; Ling Lu
Journal:  Int J Mol Sci       Date:  2011-08-31       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.